Skip to Content

Posts tagged with "Current Events"

  • Business and Markets

    Kumbaya

    Time, regrettably, for some politics. In case anyone’s wondering, my take on yesterday’s health care announcement by the Obama administration is perfectly stated here. I could not agree more. In other words, I see the “historic announcement” as nothing more than political theater. Everyone got together, held hands, and pledged to voluntaril… Read More
  • Current Events

    Faking It on Facebook

    I have no Facebook presence to speak of (for better or worse), but if you do, and if you’re involved in the pharma/biotech area, you might want to check out this report. Someone (or some group) has been setting up a whole network of fake identities there, and you have to wonder just what the… Read More
  • Current Events

    Don’t Hit The Bunkers Just Yet

    Swine flu: is it time to panic yet? Actually, it never is, and this is a particularly useless time to start running in circles, despite the apparent non-stop coverage on the cable news channels. I had some exposure to those during my recent vacation, which only confirmed the complete ban on the damned things in… Read More
  • Business and Markets

    Biogen Idec: What’s Going On?

    Biogen Idec has continued to fight off Carl Icahn, opposing his nominees to the company’s board and setting up a fight at the annual meeting later this year. But this morning (as a correspondent has just pointed out to me) the company’s stock has been taking off. It’s up about 7%, with the broad market… Read More
  • Current Events

    Sponsor A Gene?

    This has been forwarded on to me – if you find the idea of a gene sequence being sponsored by IKEA unusual, you should give the press release (and its associated links) a close look. . . Read More
  • Business and Markets

    Layoffs At Merck

    I’ve been hearing for a little while about impending layoffs at Merck. I decided, though, that this isn’t the environment to be putting up posts about rumors of job cuts – everyone’s jumpy enough already. But unfortunately, they aren’t rumors any more. What I’m hearing about, in person and via e-mail, is what sounds like… Read More
  • Current Events

    Greedy Biotechs?

    Smack in the middle of the biotech district of Cambridge, at one of the busy intersections, is a whopping billboard. It’s one of those that rotate vertical segments between three faces, and for some weeks now, all three of them have proclaimed loudly “Stop Biotech Greed!” Variations on the theme include how much money biotech… Read More
  • Current Events

    Wyeth v. Levine: Pre-emption Goes Away

    The idea of preemption in drug liability cases has been coming up a lot in recent years. If the FDA approves a drug, does that Federal-level approval stop liability suits at the state level, or not? The Supreme Court has ruled today in the Wyeth v. Levine case, which directly addresses this issue. And pre-emption… Read More
  • Current Events

    Ranbaxy in Trouble

    There are reports this morning that the FDA is halting further review of drug applications from one of the largest generic drug manufacturers, India’s Ranbaxy. It appears that some test results submitted to the agency have been found to be falsified. Update: here’s the FDA’s complaint (PDF). I’m not seeing any details on wha… Read More
  • Business and Markets

    Single, Simple Numbers: Use At Your Own Risk

    I wanted to link to this excellent article by Felix Salmon over at Wired. He’s talking about the mathematical formula that convinced many people on Wall Street that they’d figured out how to price out correlated risks in debt securities. As we all now know, they’d done no such thing, even though trillions of dollars… Read More
...91011...